Wednesday, July 15, 2026
VideoAdmin
NewsWhite
This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit
BUSINESS
Unverified

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

June 4, 2026·Source: CNBC·11 views

Share This Article

The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."

Share This Article

Originally reported by CNBC. Read the original article

Related Articles

‘Beijing is laughing’ at US-Mexico-Canada stalled trade talks
BUSINESS

‘Beijing is laughing’ at US-Mexico-Canada stalled trade talks

A US trade expert says the US, Mexico, and Canada need to hold trilateral talks to get a cross-border trade deal signed.

Al Jazeera·1d ago
Trump's Hormuz toll plans bring oil supply risks back in spotlight
BUSINESS

Trump's Hormuz toll plans bring oil supply risks back in spotlight

While the proposed levy would raise shipping costs, an escalating conflict could remove barrels from the market altogether.

CNBC·1d ago
Japan’s bond market is back in play after decades in the wilderness
BUSINESS

Japan’s bond market is back in play after decades in the wilderness

JGBs have been selling off amid policy normalization and concerns over Tokyo's spending plans, but experts say that they deserve another look from investors.

CNBC·1d ago
A streaming stock risks diving below its key support level this week. Here's what else Jay Woods is watching
BUSINESS

A streaming stock risks diving below its key support level this week. Here's what else Jay Woods is watching

NYSE insider Jay Woods is keeping an eye on Netflix in advance of its latest financial results due out later this week. Here's what else he's watching.

CNBC·1d ago